In this paper, we will focus on the role of the two most frequently mutated subunits of the SWI/SNF complex, ARID1A and SMARCA4, in tumors and their molecular mechanisms, as well as the anti-tumor therapeutic strategies that have been identified for the corresponding mutations. Here, SMARCA1 is linked to neoplasm.